Literature DB >> 29677002

Immunotherapy for Sepsis: A Good Idea or Another Dead End?

Warren L Lee1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29677002     DOI： 10.1097/ALN.0000000000002237

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  4 in total

1.  Prophylactic simvastatin treatment modulates the immune response and increases survival of mice following induction of lethal sepsis.

Authors:  Le Qin; Xiaoxiao Xie; Peipei Fang; Jie Lin
Journal:  J Int Med Res       Date:  2019-07-16       Impact factor: 1.671

2.  Recombinant human milk fat globule-EGF factor VIII (rhMFG-E8) as a therapy for sepsis after acute exposure to alcohol.

Authors:  Wayne W Chaung; Max Brenner; Hao-Ting Yen; Mahendar L Ochani; Asha Jacob; Ping Wang
Journal:  Mol Med       Date:  2019-11-20       Impact factor: 6.354

Review 3.  The Critical Roles and Mechanisms of Immune Cell Death in Sepsis.

Authors:  Zhenxing Cheng; Simon T Abrams; Julien Toh; Susan Siyu Wang; Zhi Wang; Qian Yu; Weiping Yu; Cheng-Hock Toh; Guozheng Wang
Journal:  Front Immunol       Date:  2020-08-25       Impact factor: 7.561

4.  Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of CD4+ CD25+ regulatory T cells.

Authors:  Yun Ge; Man Huang; Yao Wu; Ning Dong; Yong-Ming Yao
Journal:  J Cell Mol Med       Date:  2019-12-27       Impact factor: 5.310
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.